Laboratorio Clinico Irizarry Guasch

CLIA Laboratory Citation Details

1
Total Citation
6
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 40D0667128
Address 99 Central, Carr 14 Bo Coto Laurel, Coto Laurel, PR
City Coto Laurel
State PR
Phone(787) 812-1233

Citation History (1 survey)

Survey - December 4, 2019

Survey Type: Standard

Survey Event ID: 83CJ11

Deficiency Tags: D5391 D6094 D5891 D6094 D5391 D5891

Summary:

Summary Statement of Deficiencies D5391 PREANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1249(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems specified at 493.1241 through 493.1242. This STANDARD is not met as evidenced by: Based on quality assessment procedure manual, quality assessment records review (year 2017 and 2019) and interview with the laboratory general supervisor on December 4, 2019 at 9:20 AM, it was determined that the laboratory failed to follow the established Quality Assessment Program to monitor and evaluate the following requirements for preanalytic systems: patient test requests The findings include: a. Review of the quality assessment program showed that the laboratory must evaluate the patient's test requests every year. b. Review of the quality assessment records on December 4, 2019 at 9:35 AM, showed that the last evaluation to patient test requests was performed during year 2017. c. The laboratory general supervisor state that evaluations to test requests scheduled for year 2018 and 2019 were not performed. D5891 POSTANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1299(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess and, when indicated, correct problems identified in the postanalytic systems specified in 493.1291. This STANDARD is not met as evidenced by: Based on quality assessment procedure manual, quality assessment records review (year 2017 and 2019) and interview with the laboratory general supervisor on Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- December 4, 2019 at 9:35 AM, it was determined that the laboratory failed to follow the established Quality Assessment Program to monitor and evaluate the following requirements for preanalytic systems: final patient's test results. The findings include: a. Review of the quality assessment program showed that the laboratory must evaluate the final patient's test results every year. b. Review of the quality assessment records on December 4, 2019 at 9:35 AM, showed that the last evaluation to final patient's test results was performed during year 2017. c. The laboratory general supervisor state that evaluations to final patient's test results scheduled for year 2018 and 2019 were not performed. D6094 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality assessment programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on Quality Assessment (QA) records review and laboratory general supervisor interview on December 4, 2019 at 9:20 AM, it was determined that laboratory failed to ensure compliance with quality assessment (QA) requirements. The finding includes: a. Quality Assessment records showed that the laboratory did not evaluate the established Quality Assessment Program to monitor and evaluate the requirements for preanalytic and postanalytic systems. Refer to D5391 and D5891. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access